Analyst Conference Summaries

Biotechnology Investor Aids

Bristol-Myers Squibb
RETA

conference date: July 27, 2022 @ 5:00 AM Pacific Time

Bristol Myers Squibb: Growth Plans and Q2 2022 Results [July 29, 2022] at Seeking Alpha

Bristol Myers Squibb Q2 2021 Shows Strenth And Value [July 29, 2021] at Seeking Alpha

Bristol Myers Squibb Offers Growth With A Safe Dividend [June 23, 2020] at Seeking Alpha

Bristol-Myers Squibb On Roll With Opdivo Results [October 3, 2019] at Seeking Alpha

I Plan To Keep Bristol-Myers Squibb Stock Issued For Celgene [January 15, 2019] at Seeking Alpha

2022
Bristol-Myers
Squibb
Q4 2021
Bristol-Myers
Squibb
Q1 2022
Bristol-Myers
Squibb
Q2 2022
 
Feb. 4, 2022 April 29, 2022 July 27, 2022  
2021
Bristol-Myers
Squibb
Q4 2020
Bristol-Myers
Squibb
Q1 2021
Bristol-Myers
Squibb
Q2 2021
Bristol-Myers
Squibb
Q3 2021
Feb. 4, 2021 April 29, 2021 July 28, 2021 Oct. 27, 2021
2020
Bristol-Myers
Squibb
Q4 2019
Bristol-Myers
Squibb
Q1 2020
Bristol-Myers
Squibb
Q2 2020
Bristol-Myers
Squibb
Q3 2020
Feb. 6, 2020 May 7, 2020 Aug. 6, 2020 Nov. 5, 2020
2019
Bristol-Myers
Squibb
Q4 2018
Bristol-Myers
Squibb
Q1 2019
Bristol-Myers
Squibb
Q2 2019
Bristol-Myers
Squibb
Q3 2019
Jan. 24, 2019 April 25, 2019 July 25, 2019 Oct. 31, 2019

Bristol-Myers Squibb (BMY) is a large-cap biotechnology and pharmaceutical company.

Bristol-Myers Squibb web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMGN
 APRE
 ARWR
 BIIB
 BMY
 CLDX
 EPZM
 GILD
 GLYC
 ILMN
 INO
 IONS
 ISRG
 MCHP
 MRNA
 PLX
 REGN
 RNA
 SAGE
 SGEN
 TTPH
 VBLT
 VSTM
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2022 William P. Meyers